Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04061369
Other study ID # FL106
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date April 18, 2019
Est. completion date August 31, 2019

Study information

Verified date August 2022
Source USDA, Western Human Nutrition Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators aim to establish a protocol for metabolic rate measurements obtained using continuous monitoring of oxygen consumption and carbon dioxide production in a whole room calorimeter setting.


Description:

The purpose of this study is to determine the duration and time course of the thermic effect of single meals consumed by subjects who have been previously fasting for 12 hours overnight. Capturing the full thermic effect of a meal may take up to 8 hours, depending on the calorie load, nutrient composition of the meal, and rate of digestion. The investigators will test meals consisting of conventional foods that are low (20% of energy), moderate (40% of energy) or high (60% of energy) in fat calories, as fat is thought to slow the digestive process. The investigators will test a liquid meal, that is high (60% of energy) in fat calories, as liquid foods are thought to move more quickly through the digestive process. Another purpose of this study is to determine the test-retest reproducibility for the meals described above. To accomplish reproducibility, a volunteer will be permitted to repeat a test day two times using the same test meal.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date August 31, 2019
Est. primary completion date August 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Body Mass Index 18.5 - 39.9 kg/m2 Exclusion Criteria: - BMI < 18.5 or > 40 kg/m2 - Presence of untreated or uncontrolled metabolic diseases - Presence of gastrointestinal distress or disorders that prevent consumption of a study meal (in particular, the high fat meals) - Presence of Crohn's disease, irritable bowel syndrome, or colitis - Previous gallbladder removal - Presence of cancer or other serious chronic disease - Implanted medical device that is battery operated, such as a pacemaker, defibrillator, electrocardiograph, or nerve simulator - Presence of a large amount of metal in the body such as a hip implant - Current use of tobacco in any form - Claustrophobia - Dietary restrictions that would interfere with consuming study meals - Pregnant or nursing within the last 6 months, or plan to become pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Low fat meal
Meal consisting of conventional foods that is low (20% of energy) in fat calories.
Moderate fat meal
Meal consisting of conventional foods that is moderate (40% of energy) in fat calories.
High fat meal
Meal consisting of conventional foods that is high (60% of energy) in fat calories.
High fat liquid meal
Liquid meal that is high (60% of energy) in fat calories.

Locations

Country Name City State
United States USDA, ARS, Western Human Nutrition Research Center Davis California

Sponsors (1)

Lead Sponsor Collaborator
USDA, Western Human Nutrition Research Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Baseline level and change in rate of oxygen consumption Oxygen consumption rate (VO2/min) measured by gas analyzer while inside whole room calorimeter Measured continuously from baseline up to 600 minutes post-meal
Primary Baseline level and change in rate of carbon dioxide production Carbon dioxide production rate (VCO2/min) measured by gas analyzer while inside whole room calorimeter Measured continuously from baseline up to 600 minutes post-meal
Primary Baseline level and change in respiratory exchange ratio (RER) RER is expressed as the ratio of VCO2 to VO2 Measured continuously from baseline up to 600 minutes post-meal
Primary Baseline level and change in urinary nitrogen excretion Urinary nitrogen measured via combustion and gas analysis in mg Measured from discrete specimens and a pooled urine sample collected up to 600 minutes post-meal while in the room calorimeter
Secondary Body weight measured in kg Baseline
Secondary Body fat Measured in kg using multi frequency bioimpedance Baseline
Secondary Lean body mass Measured in kg using multi frequency bioimpedance Baseline
Secondary Total body water Measured in kg using multi frequency bioimpedance Baseline
Secondary Waist circumference measured in cm Baseline
Secondary Hip circumference measured in cm Baseline
Secondary Blood pressure Both systolic and diastolic pressure measured in mmHg using automated instrument Baseline
Secondary Heart rate measured in beats per minute using automated instrument Baseline
Secondary Body temperature measured in centigrade Baseline
Secondary General health and well-being The SF-36 Short form general health and well-being questionnaire measured once. The survey has eight scales; physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, pain, general health. All 36 items are scored so that a high score defines a more favorable health state. Each item is scored on a 0 to 100 range so that the lowest and highest possible scores are 0 and 100, respectively. Items in the same scale are averaged together to create the 8 scale scores. Baseline
Secondary Usual physical activity Physical activity estimated from the Stanford Brief Physical Activity questionnaire. Scale is categorical for two subscales: work physical activity and leisure time activity. Baseline
Secondary Baseline level and change in satiety Self-reported feelings of fullness measured on a visual analog scale. Responses will be a marked on an unsegmented line from 0 or "not at all" to 100 or "extremely." Baseline, and 5, 10, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330, 360, 390, 420, 450, and 480 minutes after meal
Secondary Baseline level and change in hunger Self-reported feelings of hunger measured on a visual analog scale. Responses will be a marked on an unsegmented line from 0 or "not at all" to 100 or "extremely." Baseline, and 5, 10, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330, 360, 390, 420, 450, and 480 minutes after meal
Secondary Baseline level and change in desire to eat Self-reported feelings of the desire to eat measured on a visual analog scale. Responses will be a marked on an unsegmented line from 0 or "not at all" to 100 or "extremely." Baseline, and 5, 10, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330, 360, 390, 420, 450, and 480 minutes after meal
Secondary Baseline level and change in prospective consumption Self-reported feelings of prospective consumption measured on a visual analog scale. Responses will be a marked on an unsegmented line from 0 or "not at all" to 100 or "extremely." Baseline, and 5, 10, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330, 360, 390, 420, 450, and 480 minutes after meal
Secondary Baseline level and change in energy expenditure Calculated as kcal/min from oxygen consumption and carbon dioxide production (L/min) and urinary nitrogen excretion (g/min) Expressed from baseline up to 600 minutes post-meal
Secondary Baseline level and change in carbohydrate combustion Calculated as g/min from oxygen consumption and carbon dioxide production (L/min) and urinary nitrogen excretion (g/min) Expressed from baseline up to 600 minutes post-meal
Secondary Baseline level and change in fat combustion Calculated as g/min from oxygen consumption and carbon dioxide production (L/min) and urinary nitrogen excretion (g/min) Expressed from baseline up to 600 minutes post-meal
Secondary Baseline level and change in thermic effect of food (TEF) Calculated as the increase in post-meal energy expenditure above baseline energy expenditure Expressed from baseline up to 600 minutes post-meal
Secondary Baseline level and change in heart rate Heart rate is estimated from wrist-worn activity monitor Expressed from baseline up to 600 minutes post-meal
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2